M.S. Jacovides Hellas
M.S. Jacovides Hellas is a Greek medical device distributor, founded in 1982, that exclusively markets and distributes innovative medical technologies from international manufacturers (Terumo, Cheetah Medical, NeurOptics, Bittium) to public and private hospitals and healthcare institutions across Greece and Cyprus.
- Company typePrivate
- Founded1982
- HeadquartersAthens, Greece
- Headcount11–50
- GTM typeB2B
- OfferingServices
What M.S. Jacovides Hellas does
M.S. Jacovides Hellas S.A. is a Greek medical device distribution and marketing company headquartered in Halandri, Athens, founded in 1982 as a member of the family-owned MSJ Group (originating in Cyprus in 1944). The company introduces and markets innovative medical devices in Greece and Cyprus through exclusive marketing and distribution agreements with leading international medical technology companies, including Terumo (cardiovascular), Cheetah Medical (noninvasive hemodynamic monitoring), NeurOptics (pupillometry), and Bittium.
The company operates through two strategic business units: the Interventional Cardiology and Radiology (ICR) unit, which covers products for interventional cardiology, peripheral intervention, and oncology/embolization procedures; and the Critical Care Solutions (CCS) unit, which addresses anesthesia, operating room, intensive care, emergency departments, blood centers, hematology clinics, thoracic surgery, and interventional pulmonology. M.S. Jacovides Hellas holds ISO 9001:2015, ISO 13485:2016, and ISO 37001:2016 certifications, along with TRACE certification, supporting regulatory compliance and transparency in international commercial transactions.
The firm employs 45 personnel, with 27 in sales and scientific support, serving public and private hospitals and healthcare institutions across Greece and Cyprus. The company generates revenue through exclusive distribution agreements with international medical device manufacturers, earning margins on the resale of these products. It is privately held by the Jacovides family, with Aris M. Jacovides serving as President & Managing Director, and the four Jacovides brothers received the 2025 IN Business Awards Lifetime Achievement Award.
M.S. Jacovides Hellas firmographics
Firmographics- Name
- M.S. Jacovides Hellas
- Legal name
- M. S. Jacovides Hellas S.A.
- Website
- https://msjacovides.com
- Company type
- Private
- Founded year
- 1982
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- M.S. Jacovides Hellas is a Greek medical device distributor, founded in 1982, that exclusively markets and distributes innovative medical technologies from international manufacturers (Terumo, Cheetah Medical, NeurOptics, Bittium) to public and private hospitals and healthcare institutions across Greece and Cyprus.
- Ownership category
- akta.pro rank
M.S. Jacovides Hellas industry classification
Industry- Product category
- Medical Device Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Durable Medical Equipment (DME) & Home Health Distribution (CRAOAHAF)
- akta.pro secondary industry
- Medical Devices & Diagnostics (TLAIALAD)
Keywords
Where M.S. Jacovides Hellas is headquartered
LocationHeadquarters
- HQ city
- Athens
- HQ country
- Greece
- HQ region
- Europe
Offices2 records
Markets served
M.S. Jacovides Hellas business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Medical Device Distribution: Marketing and distribution of innovative medical devices through exclusive partnership agreements with leading international medical technology companies in Greece and Cyprus
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
M.S. Jacovides Hellas product offering
Product offeringCore offering
M.S. Jacovides Hellas markets and distributes innovative medical devices in Greece and Cyprus under exclusive agreements with leading international medical technology manufacturers. The company is organized into two business units: the Interventional Cardiology and Radiology (ICR) unit, covering interventional cardiology, peripheral intervention and oncology/embolization products, and the Critical Care Solutions (CCS) unit, covering anaesthesia, operating room, intensive care, emergency department, blood centre, haematology, thoracic surgery and interventional pneumonology products.
Product overview
M.S. Jacovides Hellas operates as a medical devices marketing and distribution company with two distinct Business Units. The Interventional Cardiology and Radiology (ICR) unit covers cardiovascular and peripheral intervention products as well as oncology/embolization procedures. The Critical Care Solutions (CCS) unit addresses anesthesia, operating room, intensive care, emergency departments, blood centers, hematology clinics, thoracic surgery, and interventional pulmonology. The company distributes products from international medical technology partners including Terumo cardiovascular surgical products, NeurOptics pupillometry devices, Cheetah Medical hemodynamic monitoring systems, and Bittium products.
Differentiator
Problem solved
Functional benefit
Products and services
- Interventional Cardiology and Radiology Business Unit (ICR)
Companies that use M.S. Jacovides Hellas
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles1 record
M.S. Jacovides Hellas technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
M.S. Jacovides Hellas partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- BittiumcoreBeginning of cooperation with the Finnish company Bittium for marketing and distribution of their products in Greece and Cyprus. Bittium specializes in secure communications and connectivity solutions.
- NeurOptics Inc.coreCollaboration for marketing and distribution of NeurOptics' NPi-300 handheld pupillometer providing objective pupillary size measurement and reactivity as the Neurological Pupil index (NPi). NeurOptics is the leader in pupillometry science, headquartered in Irvine, California with representatives in over 30 countries worldwide.
- Cheetah MedicalcoreNew partnership for exclusive marketing and distribution of Cheetah Medical's noninvasive hemodynamic monitoring devices. Cheetah Medical is the pioneer and global leading provider of 100% noninvasive hemodynamic monitoring technologies for critical care, operating room and emergency department settings. Founded in Israel in early 2000s with headquarters in Boston, Massachusetts and offices in Tel Aviv, Israel and Vancouver, Washington.
- Terumo Italia S.r.l. / Terumo Medical CorporationcoreM.S. Jacovides Hellas enhanced its agreement with Terumo Italia S.r.l. to exclusively distribute Terumo's Cardiovascular product portfolio in Greece. The agreement covers oxygenators, beating heart & surgical stabilization products, endoscopic vein harvesting systems, hemoconcentrators, cardioplegia sets and blood parameter monitoring systems for cardiac surgery procedures. Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over $5 billion in sales and operations in more than 160 nations.
Scale indicators5 records
Recent moves8 records
Expansion highlights5 records
M.S. Jacovides Hellas competitors and assessment
Company assessmentBroad incumbents
- Boston Scientific: Global interventional medical device company with major franchises in interventional cardiology, peripheral intervention, and oncology/embolization — the same procedure categories covered by M.S. Jacovides Hellas' ICR Business Unit. Comparable as a competing medtech principal targeting the same interventional cardiology customers.
- Edwards Lifesciences: Global leader in structural heart disease and critical care monitoring, overlapping with M.S. Jacovides Hellas' ICR Business Unit (interventional cardiology) and parts of CCS. Comparable as a premium medtech principal whose products are typically distributed via exclusive regional partners like M.S. Jacovides Hellas.
- Medline: One of the largest privately held medical device and supply manufacturers and distributors globally. Comparable as a large-scale medical supply distributor serving European hospitals through direct sales, illustrating the broader competitive context for specialty distributors like M.S. Jacovides Hellas.
- Getinge: Swedish medtech company specializing in surgical workflows, ICU, and sterilization — directly mirroring M.S. Jacovides Hellas' Critical Care Solutions Business Unit. Comparable as a specialist in high-acuity hospital equipment distributed into European hospital systems.
- B. Braun: Global medical device and pharmaceutical solutions company with a strong presence in hospital infusion, surgical, and critical care. Comparable because it sells medical devices directly to Greek and European hospitals through its own distribution, competing with M.S. Jacovides Hellas for the same clinical call points in ICU, OR, and interventional procedures.
- Dräger: German medical and safety technology company focused on anesthesia, intensive care, and patient monitoring — a near-direct overlap with M.S. Jacovides Hellas' CCS Business Unit (Anaesthesia, OR, ICU, Emergency Departments). Comparable as a critical-care specialist selling into the same European hospital segments.
- Mindray: Global medical device company with strong patient monitoring and critical care portfolio that overlaps with M.S. Jacovides Hellas' CCS offerings. Comparable as a broad medtech manufacturer that distributes into European hospital channels, sometimes through regional partners.
- Olympus Medical: Global medical device company with strong franchises in endoscopy, thoracic surgery, and interventional pulmonology — areas explicitly addressed by M.S. Jacovides Hellas' CCS Business Unit. Comparable as a premium medtech principal distributed into Greek and European hospitals.
- Terumo: Japanese global medical device manufacturer and M.S. Jacovides Hellas' largest disclosed principal partner. Comparable as a leading cardiovascular and interventional medtech company that competes and partners across the same interventional cardiology and radiology end markets.
Direct peers
- Genesis Pharma: Largest company in the MSJ Group (same family), founded 1997 in partnership with Costas Evripides, focused on biopharmaceuticals with offices in Central and Eastern Europe. Comparable as a sister specialty healthcare distributor/marketer leveraging the same family-owned Greek-Cypriot platform, demonstrating the Group's distribution DNA.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
M.S. Jacovides Hellas social profiles
Digital presenceM.S. Jacovides Hellas compliance and trust
Trust signalCompliance4 records
M.S. Jacovides Hellas financial estimates
Financial estimateRevenue estimate
Valuation estimate
M.S. Jacovides Hellas leadership team
Management profileNumber of profiles
Profiles1 record
M.S. Jacovides Hellas funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
M.S. Jacovides Hellas M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about M.S. Jacovides Hellas
What does M.S. Jacovides Hellas do?
M.S. Jacovides Hellas markets and distributes innovative medical devices in Greece and Cyprus under exclusive agreements with leading international medical technology manufacturers. The company is organized into two business units: the Interventional Cardiology and Radiology (ICR) unit, covering interventional cardiology, peripheral intervention and oncology/embolization products, and the Critical Care Solutions (CCS) unit, covering anaesthesia, operating room, intensive care, emergency department, blood centre, haematology, thoracic surgery and interventional pneumonology products.
Is M.S. Jacovides Hellas a public or private company?
M.S. Jacovides Hellas is a private company. It is classified as family owned and is currently operating.
When was M.S. Jacovides Hellas founded?
M.S. Jacovides Hellas was founded in 1982. It employs 11 to 50 people.
Where is M.S. Jacovides Hellas based?
M.S. Jacovides Hellas is headquartered in Athens, Greece, in the Europe region.
How does M.S. Jacovides Hellas make money?
One revenue line is on record: medical Device Distribution.
Who are M.S. Jacovides Hellas's main competitors?
Broad incumbents on record are Boston Scientific, Edwards Lifesciences, Medline, Getinge, B. Braun, Dräger, Mindray, Olympus Medical and Terumo. Genesis Pharma is listed as a direct peer.
Does M.S. Jacovides Hellas have an API?
No public API is recorded for M.S. Jacovides Hellas.
What industry is M.S. Jacovides Hellas in?
M.S. Jacovides Hellas's product category is Medical Device Distribution. Its primary akta.pro industry code is CRAOAHAF, Durable Medical Equipment (DME) & Home Health Distribution, with a secondary code of TLAIALAD, Medical Devices & Diagnostics. Its NAICS code is 42421 and its SIC code is 5047.